Skip to content

First Turn Management, LLC

Follow

13F filer, CIK 1993440, DEL MAR, CA

First Turn Management, LLC reported $752,975,725 across 38 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 43.95% of the portfolio.

Accepted , ingested 13F-HR 0001993440-26-000005

Period
2026-09-30
Reported value
$753M
Holdings
38
Top 10 weight
43.95%
New
13
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GHnew+219,304$39.1M
CRLnew+86,801$25.6M
RGENnew+108,436$20.8M
TNGXnew+766,860$19.1M
MANEnew+136,718$16.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RVMDreduced-322,991-$66.3M
MIRMexited-218,051-$25.5M
APGEexited-138,822-$18.4M
BBIOreduced-278,993-$18.4M
PCVXreduced-306,302-$17.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001993440-26-000005, largest first. % of portfolio is the value over $752,975,725, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 535,092 shares; 2025Q1: 535,092 shares; 2025Q2: 509,987 shares; 2025Q3: 783,411 shares; 2025Q4: not reported; 2026Q1: 623,839 shares; 2026Q2: 954,360 shares; 2026Q3: 958,700 shares 958,700$43.9M5.84%+4,340Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 315,737 shares; 2025Q2: 302,307 shares; 2025Q3: not reported; 2025Q4: 271,685 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 219,304 shares 219,304$39.1M5.19%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 291,820 shares; 2025Q4: 381,233 shares; 2026Q1: 465,869 shares; 2026Q2: 489,889 shares; 2026Q3: 384,592 shares 384,592$38.1M5.06%-105,297Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 959,703 shares; 2025Q4: 1,186,817 shares; 2026Q1: 1,190,118 shares; 2026Q2: 1,331,066 shares; 2026Q3: 985,583 shares 985,583$36M4.79%-345,483Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 85,318 shares; 2025Q4: 63,580 shares; 2026Q1: 104,726 shares; 2026Q2: 84,932 shares; 2026Q3: 60,064 shares 60,064$32.5M4.32%-24,868Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 690,528 shares; 2026Q1: 911,337 shares; 2026Q2: 1,670,000 shares; 2026Q3: 1,525,220 shares 1,525,220$31.4M4.17%-144,780Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 192,146 shares; 2025Q1: 118,179 shares; 2025Q2: 144,400 shares; 2025Q3: 152,614 shares; 2025Q4: 206,921 shares; 2026Q1: 188,772 shares; 2026Q2: 218,415 shares; 2026Q3: 162,407 shares 162,407$29.9M3.98%-56,008Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 446,980 shares; 2025Q1: 401,629 shares; 2025Q2: 372,672 shares; 2025Q3: 319,773 shares; 2025Q4: 264,293 shares; 2026Q1: 248,475 shares; 2026Q2: 263,851 shares; 2026Q3: 245,726 shares 245,726$28M3.72%-18,125Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 210,578 shares; 2026Q2: 329,101 shares; 2026Q3: 329,101 shares 329,101$26.2M3.48%0Timeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 86,801 shares 86,801$25.6M3.4%newTimeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 254,795 shares; 2025Q4: 325,668 shares; 2026Q1: 283,700 shares; 2026Q2: 527,412 shares; 2026Q3: 357,945 shares 357,945$23.6M3.13%-169,467Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 452,290 shares; 2025Q1: 656,699 shares; 2025Q2: 551,684 shares; 2025Q3: 589,729 shares; 2025Q4: 595,473 shares; 2026Q1: 695,718 shares; 2026Q2: 633,364 shares; 2026Q3: 354,371 shares 354,371$23.3M3.1%-278,993Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,536 shares; 2025Q1: 71,775 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,749 shares; 2026Q1: 42,441 shares; 2026Q2: 83,528 shares; 2026Q3: 78,806 shares 78,806$23M3.05%-4,722Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,451,037 shares; 2025Q1: 2,027,430 shares; 2025Q2: 2,009,923 shares; 2025Q3: 2,159,474 shares; 2025Q4: 2,010,307 shares; 2026Q1: 2,017,284 shares; 2026Q2: 2,017,284 shares; 2026Q3: 1,574,334 shares 1,574,334$21.2M2.82%-442,950Timeline
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 108,436 shares 108,436$20.8M2.77%newTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 766,860 shares 766,860$19.1M2.54%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 403,915 shares; 2025Q1: 340,109 shares; 2025Q2: 415,591 shares; 2025Q3: 643,050 shares; 2025Q4: 638,385 shares; 2026Q1: 468,376 shares; 2026Q2: 415,307 shares; 2026Q3: 92,316 shares 92,316$18.9M2.52%-322,991Timeline
INBXINHIBRX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 164,783 shares; 2026Q3: 171,512 shares 171,512$17.2M2.28%+6,729Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 521,097 shares; 2025Q3: 716,971 shares; 2025Q4: 893,473 shares; 2026Q1: 558,336 shares; 2026Q2: 582,497 shares; 2026Q3: 702,396 shares 702,396$17.1M2.27%+119,899Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 136,718 shares 136,718$16.6M2.2%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 824,283 shares; 2026Q1: 947,339 shares; 2026Q2: 602,281 shares; 2026Q3: 514,976 shares 514,976$16.5M2.19%-87,305Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 220,921 shares; 2026Q2: 285,771 shares; 2026Q3: 178,573 shares 178,573$15.7M2.09%-107,198Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 148,093 shares; 2026Q2: 156,450 shares; 2026Q3: 109,871 shares 109,871$15.2M2.01%-46,579Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 146,303 shares; 2026Q1: not reported; 2026Q2: 154,018 shares; 2026Q3: 157,603 shares 157,603$15M1.99%+3,585Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 565,142 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 577,693 shares 577,693$14.9M1.98%newTimeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 222,649 shares 222,649$14.6M1.94%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 299,464 shares; 2025Q3: 397,693 shares; 2025Q4: 153,206 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 220,666 shares 220,666$14.4M1.92%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 867,639 shares; 2026Q2: 1,221,721 shares; 2026Q3: 913,452 shares 913,452$13.4M1.78%-308,269Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 93,727 shares 93,727$13.1M1.74%newTimeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 277,726 shares; 2025Q4: 206,445 shares; 2026Q1: 254,672 shares; 2026Q2: 102,533 shares; 2026Q3: 113,299 shares 113,299$12.7M1.68%+10,766Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,877 shares; 2026Q3: 54,594 shares 54,594$12.4M1.65%-50,283Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 321,655 shares; 2026Q1: 615,489 shares; 2026Q2: 608,925 shares; 2026Q3: 465,474 shares 465,474$11.2M1.49%-143,451Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 684,986 shares; 2025Q1: 683,451 shares; 2025Q2: 660,617 shares; 2025Q3: 799,743 shares; 2025Q4: 799,743 shares; 2026Q1: 786,844 shares; 2026Q2: 600,200 shares; 2026Q3: 297,060 shares 297,060$11M1.47%-303,140Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 102,541 shares 102,541$9.13M1.21%newTimeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 501,724 shares 501,724$8.48M1.13%newTimeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 216,531 shares 216,531$8.24M1.09%newTimeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 276,905 shares; 2025Q1: 276,905 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 443,836 shares; 2026Q3: 137,534 shares 137,534$7.83M1.04%-306,302Timeline
HNGEHINGE HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,448 shares 75,448$7.34M0.97%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MIRMMIRUM PHARMACEUTICALS INC218,051$25.5Mshares
APGEAPOGEE THERAPEUTICS INC138,822$18.4Mshares
SRRKSCHOLAR ROCK HLDG CORP271,227$14.9Mshares
ORKAORUKA THERAPEUTICS INC155,343$14.8Mshares
SIONSIONNA THERAPEUTICS INC110,493$4.86Mshares
NUVLNUVALENT INC26,298$3.25Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001993440-26-000005 base2026-11-16